Cleared Traditional

K233200 - XPLUS 35 Series (XPLUS 35, XPLUS 35FD) (FDA 510(k) Clearance)

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K233200 · GEMSS HEALTHCARE CO., LTD. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2023
Decision
49d
Days
Class 2
Risk

K233200 is an FDA 510(k) clearance for the XPLUS 35 Series (XPLUS 35, XPLUS 35FD). Classified as Interventional Fluoroscopic X-ray System (product code OWB), Class II - Special Controls.

Submitted by GEMSS HEALTHCARE CO., LTD. (Paju-Si, KR). The FDA issued a Cleared decision on November 16, 2023 after a review of 49 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1650 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all GEMSS HEALTHCARE CO., LTD. devices

Submission Details

510(k) Number K233200 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2023
Decision Date November 16, 2023
Days to Decision 49 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 107d · This submission: 49d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OWB Interventional Fluoroscopic X-ray System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1650
Definition Interventional Fluoroscopy
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Mtech Group, LLC
Dave Kim

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OWB Interventional Fluoroscopic X-ray System

All 318
Devices cleared under the same product code (OWB) and FDA review panel - the closest regulatory comparables to K233200.
Intelligent NR
K252503 · Canon, Inc. · Apr 2026
ARTIS icono floor
K254173 · Siemens Medical Solutions USA, Inc. · Apr 2026
ARTIS genio floor
K253752 · Siemens Medical Solutions USA, Inc. · Apr 2026
BELLIGER ACE
K252229 · Genoray Co., Ltd. · Apr 2026
Trinias
K252099 · Shimadzu Corporation · Mar 2026
Alphenix, INFX-8000V/B, INFX-8000V/S, V9.6 with aEvolve Imaging (FOV Extension)
K253584 · Canon Medical Systems Corporation · Mar 2026